[ Price : $8.95]
Amgen files suit against Hospira over its alleged failure to disclose to Amgen its manufacturing information under the Biologics P...[ Price : $8.95]
A New York federal judge says labeling for Cephalons Treanda adequately warned of potential adverse effects cited in a failure-to-...[ Price : $8.95]
FDA clears an Advanced Catheter Therapies (ACT) 510(k) for the Occlusion Perfusion Catheter that allows additional sizes for the u...[ Price : $8.95]
A Science Board subcommittee acknowledges FDA science improvements since a critical 2007 report and urges additional steps in the ...[ Price : $8.95]
FDA issues a warning on the risk for dosing errors with Forest Pharmaceuticals intravenous antibacterial drug Avycaz (ceftazidime ...[ Price : $8.95]
In its latest batch of Warning Letters, FDA cites Chaotic Labz, CMP Industries, NSC Pearson, and Sironis.[ Price : $8.95]
Federal Register Notice: FDA submits a proposed collection of information on request for samples and protocols to the Office of Ma...[ Price : $8.95]
Federal Register Final order: FDA classifies the oral electronic vision aid into Class 2.